Hepion Pharmaceuticals Inc

NASDAQ:HEPA  
1.03
-0.02 (-1.90%)
Products

Hepion Pharmaceuticals Receives FDA Fast Track Designation For CRV431 For The Treatment Of NASH

Published: 11/30/2021 14:33 GMT
Hepion Pharmaceuticals Inc (HEPA) - Hepion Pharmaceuticals Receives FDA Fast Track Designation for Crv431 for the Treatment of Nash.